pubmed.ncbi.nlm.nih.gov

High-risk elderly patients PROSPER from cholesterol-lowering therapy - PubMed

  • ️Tue Jan 01 2002

Comment

High-risk elderly patients PROSPER from cholesterol-lowering therapy

Rory Collins et al. Lancet. 2002.

No abstract available

PubMed Disclaimer

Comment in

  • The PROSPER trial.

    Little PJ. Little PJ. Lancet. 2003 Feb 1;361(9355):428. doi: 10.1016/S0140-6736(03)12400-2. Lancet. 2003. PMID: 12573396 No abstract available.

Comment on

  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

    Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources